) -8.32% SHAREHOLDERS' EQUITY Issued and paid-up share capital 1,316.25 1,316.25 0.00 0.00% Premium on ordinary shares 264.33 264.33 - 0.00% Surplus - warrants 310.00 310.00 - 0.00% Retained earnings
total shareholders’ equity of THB 290.04 million, a THB 6.95 million or 2.34% decrease from the end of the previous year (end of 2018: THB 296.99 million) mainly due to the dividend paid during the year
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
assets compared to the year 2018 (December 31st, 2018) totaling of 4,876.2 million baht, or 17.9%, mainly from Project development costs for sale which paid in advance for the future developments, an
modules of a software system 4. User Acceptance Test (UAT) Project Grand Total Related company name Paid Up Capital No. of shares Name of connected persons Share (s) in related company % of share in AEONTS
. Advance payment for purchase of land as of 30 June 2017 amounted to Baht 209 million. An India’s subsidiary had paid advance payment for a purchase of 125 Acres (approx. 316 Rais) plot of land amounting INR
margin was 44.99%. The margin was slightly decreased from the same period of 2016 as a result of event arrangement such as “FN Thank you sale” in late of March 2017 and “Celebrate 20 years: paid the second
Baht 2.71 million or equivalent to 85.76%, mainly due to decreasing of interest expense from bill of exchange in amount of Baht 2.85 million. At present, the Company already paid for bill of exchange